Nimesha Gerlus

Neurobiological biomarkers of response to ketamine.

Advances in pharmacology (San Diego, Calif.) 2020 Bashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter et al. 35 citations

As a field, psychiatry is undergoing an exciting paradigm shift toward early identification and intervention that will likely minimize both the burden associated with severe mental illnesses as well as their duration. In this context, the rapid-acting antidepressant ketamine has revolutionized our understanding of antidepressant response and greatly expanded the pharmacologic armamentarium for...